Regulation of immunity by self-reactive T cells

Nature

Volumn 435, Issue 7042, 2005, Pages 598-604

  Kronenberg, Mitchell ^a   Rudensky, Alexander ^b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASES; IMMUNOLOGY; TUMORS;

FOREIGN ANTIGENS; LYMPHOCYTES; SELF-REACTIVE CELLS; T CELLS;

CELLS;

AUTOANTIBODY; CD1D ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

MEDICINE;

ANIMAL MODEL; ARTHRITIS; ASTHMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DIABETES MELLITUS; HUMAN; IMMUNE SYSTEM; MAST CELL; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; TRANSGENIC MOUSE; ANIMAL; CELL LINEAGE; CLASSIFICATION; CYTOLOGY; IMMUNOLOGY;

ANIMALIA; MUS MUSCULUS;

ANIMALS; AUTOIMMUNITY; CELL LINEAGE; CYTOKINES; HUMANS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 20444490383     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03725     Document Type: Review

References (86)

1. Janeway, C. A. Jr Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1-13 (1989).
2. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
3. Bendelac, A., Rivera, M. N., Park, S. H. & Roark, J. H. Mouse CD1-specific NK1T cells: development, specificity and function. Annu. Rev. Immunol. 15, 535-562 (1997).
4. Treiner, E. et al. Selection of evolutionary conserved mucosal-associated invariant T cells by MRI. Nature 422, 164-169 (2003).
5. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
6. + suppressor T cells: more questions than answers. Nature Rev. Immunol. 2, 389-400 (2002).
7. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166, 3008-3018 (2001).
8. +) suppressor T cells in vivo. Nature Immunol. 3, 33-41 (2002).
9. + regulatory T cells in the steady state. J. Exp. Med. 198, 737-746 (2003).
10. Klein, L., Khazaie, K. & von Boehmer, H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl Acad. Sci. USA 100, 8886-8891 (2003).
11. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467-1477 (2004).
12. + regulatory T cells in vivo. J. Exp. Med. 198, 249-258 (2003).
13. Barthlott, T., Kassiotis, G. & Stockinger, B. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197, 451-460 (2003).
14. + T cells for IL-2 and exploit it for the induction of IL-10 production. Int. Immunol. 17, 279-288 (2005).
15. + T cell suppressor function. J. Immunol. 172, 6519-6523 (2004).
16. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004 (1999).
17. + T cells. J. Exp. Med. 183, 2669-2674 (1996).
18. Paust, S., Lu, L., McCarty, N. & Cantor, H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl Acad. Sci. USA 101, 10398-10403 (2004).
19. Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunol. 4, 1206-1212 (2003).
20. Mellor, A. L. & Munn, D. H. IDO-expression by dendritic cells: tolerance and tryptophan calabolism. Nature Rev. Immunol. 4, 762-774 (2004).
21. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783-1786 (2005).
22. Grossman, W. J. et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589-601 (2004).
23. + regulatory T cells. Nature Immunol. 4, 330-336 (2003).
24. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
25. + T regulatory cells. Nature Immunol. 4, 337-342 (2003).
26. Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genet. 27, 20-21 (2001).
27. Brunkow, M. E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genet. 27, 68-73 (2001).
28. Chatila, T. A. et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106, R75-R81 (2000).
29. Oswald-Richter, K. et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2, E198 (2004),
30. + regulatory T cells. Int. Immunol. 16, 1643-1656 (2004).
31. Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
32. Taguchi, O. et al. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology 82, 365-369 (1994).
33. Seddon, B. & Mason, D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189, 877-882 (1999).
34. +) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 188, 1883-1894 (1998).
35. + regulatory T cells induced by an agonist self-peptide. Nature Immunol. 2, 301-306 (2001).
36. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nature Immunol. 3, 756-763 (2002).
37. + T cell receptors. Immunity 21, 267-277 (2004).
38. van Sarten, H. M., Benoist, C. & Mathis, D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200, 1221-1230 (2004).
39. Modigliani, Y. et al. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur. J. Immunol. 26, 1807-1815 (1996).
40. Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387-396 (1996).
41. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440 (2000).
42. +) regulatory T cell function. J. Exp. Med. 196, 851-857 (2002).
43. Malek, T. R. & Bayer, A. L. Tolerance, not immunity, crucially depends on IL-2. Nature Rev. Immunol. 4, 665-674 (2004).
44. Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408 (2004).
45. + regulatory T cells by peripheral expansion. J. Immunol. 173, 7259-7268 (2004).
46. - T cells. J. Clin. Invest. 112, 1437-1443 (2003).
47. Godfrey, D. I. & Kronenberg, M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. invest. 114, 1379-1388 (2004).
48. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J. & Van Kaer, L. NKT cells: what's in a name? Nature Rev. Immunol. 4, 237-237 (2004).
49. Morita, M. et al. Structure-activity relationship of α- galactosylceramides against B16-bearing mice. J. Med. Chem. 38, 2176-2187 (1995).
50. Kronenberg, M. Towards an understanding of NKT cell biology: Progress and paradoxes. Annu. Rev. Immunol. 23, 877-900 (2005).
51. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. & Bendelac, A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191, 1895-1903 (2000).
52. Matsuda, J. L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754 (2000).
53. Kawahara, K., Kuraishi, H. & Zahringer, U. Chemical structure and function of glycosphingolipids of Sphingomonas spp and their distribution among members of the α4 subclass of Proteobacteria. J. Ind. Microbiol. Biotechnol. 23, 408-413 (1999).
54. Kinjo, Y. et al. Recognition of bacterial glycolipids by natural killer T cells. Nature 434, 520-525 (2005).
55. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. 434, 525-529 (2005).
56. Gapin, L., Matsuda, J. L., Surh, C. D. & Kronenberg, M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nature Immunol. 2, 971-978 (2001).
57. + cells. J. Immunol. 164, 2412-2418 (2000).
58. Nichols K. E. et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nature Med. 11, 340-345 (2005).
59. Chung, B., Aoukaty, A., Dutz, J., Terhorst, C. & Tan, R. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174, 3153-3157 (2005).
60. Pasquier B. et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201, 695-701 (2005).
61. Voyle, R. B. et al. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D. J. Exp. Med. 197, 919-925 (2003).
62. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004).
63. Fujii, S., Shimizu, K., Kronenberg, M. & Steinman, R. M. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide- loaded DCs. Nature Immunol. 3, 867-874 (2002).
64. H2 bias of natural killer T cells. Nature 413, 531-534 (2001).
65. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. & Brenner, M. B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nature Immunol. 4, 1230-1237 (2003).
66. Hammond, K. J. & Kronenberg, M. Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr. Opin. Immunol. 15, 683-689 (2003).
67. Beaudoin, L., Laloux, V., Novak, J., Lucas, B. & Lehuen, A. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 17, 725-736 (2002).
68. Furlan, R. et al. Activation of invariant NKT cells by αGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-γ. Eur. J. Immunol. 33, 1830-1838 (2003).
69. Jahng, A. W. et al. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1789-1799 (2001).
70. Zeng, D., Liu, Y., Sidobre, S., Kronenberg, M. & Strober, S. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J. Clin. Invest. 112, 1211-1222 (2003).
71. Akbari, O. et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nature Med. 9, 582-588 (2003).
72. Lisbonne, M. et al. Cutting edge: invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171, 1637-1641 (2003).
73. van der Vliet, H. J. et al. Circulating V(α24+) Vβ11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100, 144-148 (2001).
74. + NKT cells derived from multiple sclerosis in remission. Int. Immunol. 15, 279-288 (2003).
75. Lee, P. T. et al. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110, 793-800 (2002).
76. Sonoda, K. H. et al. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166, 42-50 (2001).
77. Matsumoto, I. et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nature Immunol. 3, 360-365 (2002).
78. Kim, H. Y. et al. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production. J. Exp. Med. 201, 41-47 (2005).
79. Baldwin, T. A., Hogquist, K. A. & Jameson, S. C. The fourth way? Harnessing aggressive tendencies in the thymus. J. Immunol. 173, 6515-6520 (2004).
80. Brossay, L. et al. CD1d-mediated recognition of an alpha- galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521-1528 (1998).
81. + NKT cells by repeated stimulation with KRN7000. J. Immunol. Methods 285, 197-214 (2004).
82. Tang, Q. et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455-1465 (2004).
83. Giaccone, G. et al. A phase I study of the natural killer T-cell ligand α-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer. Res. 8, 3702-3709 (2002).
84. + antigen-specific regulatory T cells. Proc. Natl Acad. Sci. USA 101 Suppl 2, 14622-14626 (2004).
85. Rao, P. E., Petrone, A. L. & Ponath, P. D. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J. Immunol. 174, 1446-1455 (2005).
86. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).